Total Count 76

SPIMACO - Disclosures

30/06/2025
SPIMACO shareholders OK dividend freeze for 2024
Argaam
27/03/2025
SPIMACO signs deal with China’s CNBG to supply, manufacture vaccines
Argaam
26/03/2025
SPIMACO signs agreement with CanSinoBIO to supply vaccines
Argaam
19/01/2025
SPIMACO inks sale, distribution contract for SAR 164.1M annually
ِArgaam
04/12/2024
SPIMACO says deal to buy 68% of Osmopharm, exit SPIMACO Misr scrapped
ِArgaam
14/11/2024
SPIMACO extends deadline to buy 68% of Osmopharm, exit SPIMACO Misr
Argaam
31/07/2024
SPIMACO, Altos Biologics sign deal to produce, market ALT-L9 in 16 key markets
Argaam
31/03/2024
SPIMACO board proposes to withhold 2023 dividends
Argaam
23/01/2024
SPIMACO signs term sheet to supply HPV vaccines
Argaam
17/12/2023
SPIMACO completes full acquisition of Dammam Pharma
Argaam
19/11/2023
SPIMACO’s subsidiary seals deal with Merck to manufacture type 2 diabetes meds in KSA
Argaam
15/11/2023
SPIMACO to transfer SAR 184.7 mln from reserves to offset accumulated losses
Argaam
14/11/2023
SPIMACO inks SPAs to acquire 68% of Osmopharm, divests 76.4% of SPIMACO Misr
Argaam
14/06/2023
SPIMACO secures SAR 300 mln credit facility from BSF
Argaam
11/06/2023
SPIMACO board proposes 815,000 share buyback for LTIP
Argaam
29/03/2023
SPIMACO board recommends no dividend for 2022
Argaam
07/02/2023
SPIMACO to hold virtual capital markets day to outline revamped 5-year plan today
Argaam
29/12/2022
SPIMACO signs SAR 900 mln credit facilities with SABB, Al Rajhi Bank
Argaam
25/12/2022
SPIMACO finalizes permits to occupy Riyadh administrative tower
Argaam
19/12/2022
SPIMACO set to launch revamped 5-year plan
Argaam
29/08/2022
SPIMACO signs credit facilities with 3 banks for SAR 1.26 bln
Argaam
24/03/2022
SPIMACO board plans 6% cash dividend for 2021
Argaam
17/01/2022
SPIMACO signs SAR 240 mln deal with Swiss firm to localize injection manufacturing
Argaam
18/11/2021
SPIMACO says ANORA shareholders approve voluntary liquidation, appoint liquidator
Argaam
04/11/2021
SPIMACO signs SAR 150 mln Murabaha agreement with Saudi EXIM Bank
Argaam
05/10/2021
SPIMACO signs SAR 160.3 mln contract with Ibrahim Alhodaithy International
Argaam
29/06/2021
SPIMACO announces legal measures for violations in subsidiary outside Saudi Arabia
Argaam
31/05/2021
SPIMACO shareholders approve 10% cash dividend for 2020
Argaam
28/04/2021
SPIMACO inks final agreement with Swiss pharma firm to locally manufacture immunosuppressive drug
Argaam
23/03/2021
SPIMACO plans 10% cash dividend for 2020
Argaam
24/01/2021
SPIMACO says fire erupted at warehouse of 51%-owned subsidiary
Argaam
29/11/2020
SPIMACO signs MoU with German firm to provide COVID-19 vaccine in Saudi Arabia
Argaam
10/11/2020
SPIMACO’s Morocco plant approves capital hike to continue project finance
Argaam
20/09/2020
SPIMACO signs MoU with Johnson & Johnson subsidiary to transfer, nationalize pharma technology
Argaam
17/09/2020
SPIMACO to voluntary liquidate a subsidiary
Argaam
16/09/2020
SPIMACO sells part of equity investment portfolio for SAR 482 mln
Argaam
18/08/2020
SPIMACO says accumulated losses down to 19.13% of capital as of June 30
Argaam
17/05/2020
SPIMACO approves 5% cash dividend for FY2019
Argaam
29/04/2020
SPIMACO signs deal with Amgen to market a biotech medicine
Argaam
19/04/2020
SPIMACO says difficult to determine financial impact of COVID-19 measures
Argaam
31/03/2020
SPIMACO board recommends 5% dividend for FY 2019
Argaam
08/12/2019
SPIMACO receives initial findings of its associate company’s fraud case
Argaam
27/08/2019
SPIMACO gets SAR 150 mln loan from SIDF to boost exports
Argaam
03/04/2019
SPIMACO appoints new chairman
Argaam
03/04/2019
SPIMACO approves 10% dividend for H2 2018
Argaam
05/03/2019
SPIMACO Egypt approves amending capital hike
Argaam
05/03/2019
SPIMACO recommends 10% dividend for H2 2018
Argaam
13/01/2019
SPIMACO refuses shareholder request to sack board of directors
Argaam
27/12/2018
SPIMACO approves Dammam Pharma's 50% capital hike
Argaam
27/11/2018
SPIMACO to discuss board dismissal, new audit committee in January
Argaam

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2025, Argaam Investment, All Rights Reserved
Call Request